Despite engaging with more than 30 potential buyers and receiving five nonbinding offers, the company did not receive any final proposals and has decided to move forward independently, according to a press release.
The review, which began in May 2024, explored various options to maximize shareholder value, including a potential acquisition. Veradigm’s board of directors, alongside financial and legal advisers, evaluated bids from strategic partners and financial sponsors but ultimately determined that continuing as an independent entity was the best path forward.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
